Skip to content
10-K

Annual Report

XBIOTECH INC. XBIT

0001171843-25-001527

← back to feed
Filed
Mar 18, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Stock Repurchased FY 2024 · Dec 31, 2024 $0
Stock Repurchased FY 2024 · Dec 31, 2023 $14K
Shares Diluted FY 2024 · Dec 31, 2023 30.44M sh
Capex FY 2024 · Dec 31, 2023 $362K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$18.73M
Cash And Equivalents FY 2024 · Dec 31, 2023 $200.02M
Current Liabilities FY 2024 · Dec 31, 2023 $6.1M
Total Liabilities FY 2024 · Dec 31, 2023 $7.77M
Current Assets FY 2024 · Dec 31, 2023 $201.72M
Total Assets FY 2024 · Dec 31, 2023 $226.62M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.81
Eps Basic FY 2024 · Dec 31, 2023 −$0.81
Sga Expense FY 2024 · Dec 31, 2023 $4.66M
Rd Expense FY 2024 · Dec 31, 2023 $32.85M
Net Income FY 2024 · Dec 31, 2023 −$24.56M
Operating Income FY 2024 · Dec 31, 2023 −$37.51M
Stockholders Equity FY 2024 · Dec 31, 2022 $240.4M